NP-PL-MNU-OGM-230006, 10.2024
Sekcja I -
Znaczenie kontroli choroby w leczeniu astmy
Postępowanie w astmie oparte na kontroli choroby

GINA 2023

Slajd 3

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2015. Available from: GINA-2015-main-report-final-WMSA.pdf (ginasthma.org)

Slajd 4

1. Brak referencji

Slajd 5

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2024. Available from: 2024 GINA Main Report - Global Initiative for Asthma - GINA (ginasthma.org)

Slajd 6

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2024. Available from: 2024 GINA Main Report - Global Initiative for Asthma - GINA (ginasthma.org)

Slajd 7

1. Woolcock, Clin Exp Allergy Rev 2001

Slajd 8

1. Brak referencji

Slajd 9

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2019. Available from http://ginasthma.org/gina-reports/;
2. Price D et al. Npj Primary Care Respir Med. 2014;24:14009;
3. Levy ML et al. Prim Care Respir J. 2013;22(4):406-11;
4. Price D et al. Respir Med 2013;107:37-46;
5. Sanchis J et al. Chest 2016;150(2):394-406;
6. van der Palen J et al. Eur Respir J. 1999;14(5):1034-7.

Slajd 10

1. Canonica GW et al. Allergy 2007

Slajd 11

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2024. Available from: 2024 GINA Main Report - Global Initiative for Asthma - GINA (ginasthma.org)

Slajd 12

1. Światowa Inicjatywa na rzecz Zwalczania Astmy. Raport 2019 GINA, Światowa Strategia Leczenia i Profilaktyki Astmy. http://www.ginasthma.org. Dostęp: 12 czerwca 2019 r.;
2. Holgate ST i wsp. Nat Rev Dis Primers. 2015;1:15025;
3. Wenzel SE. Nat Med. 2012;18:716-725;
4. Peters SP i wsp. J Allergy Clin Immunol Pract. 2017;5:S15-S24;
5. Mukherjee M i wsp. World Allergy Organ J. 2014;7:32.